[Federal Register Volume 79, Number 66 (Monday, April 7, 2014)]
[Rules and Regulations]
[Page 18990]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-07702]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 556 and 558
[Docket No. FDA-2014-N-0002]
Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug
Applications for Combination Drug Medicated Feeds Containing an
Arsenical Drug; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of withdrawal of approval; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) published a document in
the Federal Register of February 27, 2014, concerning the voluntary
withdrawal of approval of new animal drug applications (NADAs). The
document contained an incorrect list of NADAs.
DATES: This correction is effective April 7, 2014.
FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-276-9019,
[email protected].
SUPPLEMENTARY INFORMATION: In FR Doc. 2014-02616, appearing on page
10974 in the Federal Register of February 27, 2014, the following
corrections are made:
On page 10974, in the third column, in the 2d line of the
``SUMMARY'' section remove ``69'' and add in its place ``68''.
On page 10975, the first bulleted text ``Huvepharma AD, 5th Floor,
3A Nikolay Haitov Str., 1113 Sofia, Bulgaria has requested that FDA
withdraw approval of the following 16 NADAs and 8 ANADAs'' is corrected
to read ``Huvepharma AD, 5th Floor, 3A Nikolay Haitov Str., 1113 Sofia,
Bulgaria, has requested that FDA withdraw approval of the following 15
NADAs and 8 ANADAs''; and on the same page in the table, the entry
``013-461 3-NITRO (roxarsone)/AMPROL Plus (amprolium and ethopabate).''
is removed.
Dated: April 2, 2014.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2014-07702 Filed 4-4-14; 8:45 am]
BILLING CODE 4160-01-P